About NASCENT BIOTECH INC
Nascent Biotech is a biotechnology company focused on developing human antibody-based treatments for cancer, with a lead product called Pritumumab. The company utilizes proprietary technology to derive natural human antibodies from B-cells isolated from patients with cancer.
Development of human monoclonal antibodies for cancer treatmentProprietary platform technology for antibody derivationResearch and development of therapeutic products for multiple indications including cancer, diabetes, autoimmunity, and transplantation
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NASCENT BIOTECH INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.